BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21812539)

  • 21. CD40 ligand in CLL pathogenesis and therapy.
    Schattner EJ
    Leuk Lymphoma; 2000 May; 37(5-6):461-72. PubMed ID: 11042507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting neddylation induces DNA damage and checkpoint activation and sensitizes chronic lymphocytic leukemia B cells to alkylating agents.
    Paiva C; Godbersen JC; Berger A; Brown JR; Danilov AV
    Cell Death Dis; 2015 Jul; 6(7):e1807. PubMed ID: 26158513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of the CD95 receptor and defect CD40-mediated signal transduction in B-chronic lymphocytic leukemia cells.
    Laytragoon-Lewin N; Duhony E; Bai XF; Mellstedt H
    Eur J Haematol; 1998 Oct; 61(4):266-71. PubMed ID: 9820634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia.
    van Attekum MHA; Terpstra S; Slinger E; von Lindern M; Moerland PD; Jongejan A; Kater AP; Eldering E
    Oncogene; 2017 Jun; 36(26):3651-3660. PubMed ID: 28192408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1.
    Pedersen IM; Kitada S; Leoni LM; Zapata JM; Karras JG; Tsukada N; Kipps TJ; Choi YS; Bennett F; Reed JC
    Blood; 2002 Sep; 100(5):1795-801. PubMed ID: 12176902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tipping the Noxa/Mcl-1 balance overcomes ABT-737 resistance in chronic lymphocytic leukemia.
    Tromp JM; Geest CR; Breij EC; Elias JA; van Laar J; Luijks DM; Kater AP; Beaumont T; van Oers MH; Eldering E
    Clin Cancer Res; 2012 Jan; 18(2):487-98. PubMed ID: 22128299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells.
    Romano C; De Fanis U; Sellitto A; Dalla Mora L; Chiurazzi F; Giunta R; Rotoli B; Lucivero G
    Leuk Lymphoma; 2003 Nov; 44(11):1963-71. PubMed ID: 14738151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phorbol myristate acetate, but not CD40L, induces the differentiation of CLL B cells into Ab-secreting cells.
    Ghamlouch H; Ouled-Haddou H; Guyart A; Regnier A; Trudel S; Claisse JF; Fuentes V; Royer B; Marolleau JP; Gubler B
    Immunol Cell Biol; 2014 Aug; 92(7):591-604. PubMed ID: 24797583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of T cell/B cell interaction by B-CLL cells.
    Kneitz C; Goller M; Wilhelm M; Mehringer C; Wohlleben G; Schimpl A; Tony HP
    Leukemia; 1999 Jan; 13(1):98-104. PubMed ID: 10049067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
    de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
    Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Of Lymph Nodes and CLL Cells: Deciphering the Role of CCR7 in the Pathogenesis of CLL and Understanding Its Potential as Therapeutic Target.
    Cuesta-Mateos C; Brown JR; Terrón F; Muñoz-Calleja C
    Front Immunol; 2021; 12():662866. PubMed ID: 33841445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity.
    Smit LA; Hallaert DY; Spijker R; de Goeij B; Jaspers A; Kater AP; van Oers MH; van Noesel CJ; Eldering E
    Blood; 2007 Feb; 109(4):1660-8. PubMed ID: 17038534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease.
    Mittal AK; Chaturvedi NK; Rai KJ; Gilling-Cutucache CE; Nordgren TM; Moragues M; Lu R; Opavsky R; Bociek GR; Weisenburger DD; Iqbal J; Joshi SS
    Mol Med; 2014 Jul; 20(1):290-301. PubMed ID: 24800836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD40 ligation inhibits IL-2 and SAC+IL-2 induced proliferation in chronic lymphocytic leukaemia cells.
    Söderberg O; Christiansen I; Carlsson M; Nilsson K
    Scand J Immunol; 1997 Jun; 45(6):706-14. PubMed ID: 9201312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heat shock protein-90 inhibitor, NVP-AUY922, is effective in combination with fludarabine against chronic lymphocytic leukemia cells cultured on CD40L-stromal layer and inhibits their activated/proliferative phenotype.
    Best OG; Mulligan SP
    Leuk Lymphoma; 2012 Nov; 53(11):2314-20. PubMed ID: 22646928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting antigen-independent proliferation in chronic lymphocytic leukemia through differential kinase inhibition.
    Slinger E; Thijssen R; Kater AP; Eldering E
    Leukemia; 2017 Dec; 31(12):2601-2607. PubMed ID: 28462919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of TAp73 by platinum-based compounds to overcome drug resistance in p53 dysfunctional chronic lymphocytic leukemia.
    Tonino SH; Mulkens CE; van Laar J; Derks IA; Suo G; Croon-de Boer F; van Oers MH; Eldering E; Wang JY; Kater AP
    Leuk Lymphoma; 2015; 56(8):2439-47. PubMed ID: 25511680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymph node-induced immune tolerance in chronic lymphocytic leukaemia: a role for caveolin-1.
    Gilling CE; Mittal AK; Chaturvedi NK; Iqbal J; Aoun P; Bierman PJ; Bociek RG; Weisenburger DD; Joshi SS
    Br J Haematol; 2012 Jul; 158(2):216-231. PubMed ID: 22571278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced Costimulatory Signaling Improves CAR T-cell Effector Responses in CLL.
    Collins MA; Jung IY; Zhao Z; Apodaca K; Kong W; Lundh S; Fraietta JA; Kater AP; Sun C; Wiestner A; Melenhorst JJ
    Cancer Res Commun; 2022 Sep; 2(9):1089-1103. PubMed ID: 36922932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thioredoxin, produced by stromal cells retrieved from the lymph node microenvironment, rescues chronic lymphocytic leukemia cells from apoptosis in vitro.
    Bäckman E; Bergh AC; Lagerdahl I; Rydberg B; Sundström C; Tobin G; Rosenquist R; Linderholm M; Rosén A
    Haematologica; 2007 Nov; 92(11):1495-504. PubMed ID: 18024398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.